COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.


Clinical trials – Supplements for COVID-19 fatigue.

Study was conducted on 200 patients across three centres.


Clinical Trial in Brazil – CCR5 Antagonist to treat severe COVID-19 Symptoms.

Leronlimab is a CCR5 antagonist with the potential for multiple therapeutic indications.


First-in-Human – Trial of nanocellular vaccine for Covid-19.

EnGeneIC has started dosing in Phase I clinical trial of the world’s first nanocellular technology-based anti-Covid-19 vaccine in healthy adults.


COVID-19 – OK to test drug based on human immunoglobulin.

Chinese drugmaker Sinopharm has gained approval to launch clinical trials of a COVID-19 drug based on human immunoglobulin derived from vaccinated people, the company said recently.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.